Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks A Peixoto, M Relvas-Santos, R Azevedo, LL Santos, JA Ferreira Frontiers in oncology 9, 380, 2019 | 250 | 2019 |
Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review R Azevedo, JA Ferreira, A Peixoto, M Neves, N Sousa, A Lima, LL Santos Journal of controlled release 214, 40-61, 2015 | 152 | 2015 |
Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension A Peixoto, E Fernandes, C Gaiteiro, L Lima, R Azevedo, J Soares, ... Oncotarget 7 (39), 63138, 2016 | 80 | 2016 |
SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms as Predictors of Methotrexate-Related Toxicity in Portuguese Rheumatoid Arthritis Patients A Lima, M Bernardes, R Azevedo, J Monteiro, H Sousa, R Medeiros, ... Toxicological Sciences 142 (1), 196-209, 2014 | 73 | 2014 |
Future perspectives of Smartphone applications for rheumatic diseases self-management R Azevedo, H Sousa, J Monteiro, A Lima Rheumatology international 35 (3), 419-431, 2015 | 67 | 2015 |
Targeted O‐glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced‐stage bladder tumours S Cotton, R Azevedo, C Gaiteiro, D Ferreira, L Lima, A Peixoto, ... Molecular oncology 11 (8), 895-912, 2017 | 66 | 2017 |
Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients A Lima, V Seabra, M Bernardes, R Azevedo, H Sousa, R Medeiros PloS one 9 (10), e108165, 2014 | 54 | 2014 |
Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics A Lima, R Azevedo, H Sousa, V Seabra, R Medeiros Pharmacogenomics 14 (11), 1337-1351, 2013 | 54 | 2013 |
CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications R Azevedo, C Gaiteiro, A Peixoto, M Relvas-Santos, L Lima, LL Santos, ... Clinical proteomics 15, 1-5, 2018 | 53 | 2018 |
Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases L Lima, M Neves, MI Oliveira, L Dieguez, R Freitas, R Azevedo, C Gaiteiro, ... Urologic Oncology: Seminars and Original Investigations 35 (12), 675. e1-675. e8, 2017 | 50 | 2017 |
Pharmacogenomics of methotrexate membrane transport pathway: can clinical response to methotrexate in rheumatoid arthritis be predicted? A Lima, M Bernardes, R Azevedo, R Medeiros, V Seabra International journal of molecular sciences 16 (6), 13760-13780, 2015 | 50 | 2015 |
Smartphone application for rheumatoid arthritis self-management: cross-sectional study revealed the usefulness, willingness to use and patients’ needs R Azevedo, M Bernardes, J Fonseca, A Lima Rheumatology international 35, 1675-1685, 2015 | 47 | 2015 |
Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms A Lima, J Monteiro, M Bernardes, H Sousa, R Azevedo, V Seabra, ... BioMed research international 2014, 2014 | 47 | 2014 |
SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients A Lima, M Bernardes, H Sousa, R Azevedo, L Costa, F Ventura, V Seabra, ... Pharmacogenomics 15 (6), 807-820, 2014 | 47 | 2014 |
Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome A Lima, M Bernardes, R Azevedo, V Seabra, R Medeiros Pharmacogenomics 17 (15), 1649-1674, 2016 | 45 | 2016 |
Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology? R Azevedo, A Peixoto, C Gaiteiro, E Fernandes, M Neves, L Lima, ... Oncotarget 8 (53), 91734, 2017 | 43 | 2017 |
Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers A Lima, H Sousa, J Monteiro, R Azevedo, R Medeiros, V Seabra Pharmacogenomics 15 (12), 1611-1635, 2014 | 38 | 2014 |
Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications M Neves, R Azevedo, L Lima, MI Oliveira, A Peixoto, D Ferreira, J Soares, ... New biotechnology 49, 77-87, 2019 | 37 | 2019 |
Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer R Azevedo, J Soares, C Gaiteiro, A Peixoto, L Lima, D Ferreira, ... Talanta 184, 347-355, 2018 | 33 | 2018 |
Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology R Azevedo, J Soares, A Peixoto, S Cotton, L Lima, LL Santos, JA Ferreira Urologic oncology: seminars and original investigations 36 (5), 221-236, 2018 | 30 | 2018 |